|
1) Campbell M. Natural history of cyanotic malformations and comparison of all common cardiac malformations. Br Heart J. 1972; 34: 3-8
|
|
|
|
2) Niwa K, Perloff JK, Webb GD, et al. Survey of specialized tertiary care facilities for adults with congenital heart disease. Int J Cardiol. 2004; 96: 211-6
|
|
|
|
|
3) Perloff JK, Rosove MH, Sietsema KE, et al. Cyanotic congenital heart disease: a multisystem disorder. In: Perloff JK, Child JS, editors. Congenital Heart Disease in Adults. 2nd ed. Philadelphia: WB Saunders; 1998. p. 199-226
|
|
|
|
|
|
4) Engelfriet P, Boersma E, Oechslin E, et al. The spectrum of adult congenital heart disease in Europe: morbidity and morntality in a 5 year follow-up period-The Euro Heart Survey on adult congenital heart disease. Eur Heart J. 2005; 26: 2325-33
|
|
|
|
|
|
5) Oya H, Nagaya N, Miyatake K, et al. Haemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndrome. Heart. 2000; 84: 53-8
|
|
|
|
|
|
6) Oya H, Nagaya N, Miyatake K, et al. Poor prognosis and related factors in adults with Eisenmenger syndrome. Am Heart J. 2002; 143: 739-44
|
|
|
|
|
|
7) 坂崎尚徳. チアノーゼを残したまま成人期に達した先天性心疾患症例の検討. 日児誌. 2004; 108: 983-7
|
|
|
|
|
8) 姫野和家子, 赤木禎治, 松石豊次郎, 他. 肺高血圧のために手術不能と判断された先天性心疾患—成人期の問題と管理—. 日小循誌. 2005; 21: 2-7
|
|
|
|
|
|
9) Sakazaki H, Niwa K, Echigo S, et al. Predictive factors for long-term prognosis in adults with cyanotic congenital heart disease—Japanese multi-center study—. Int J Cardiol. 2007; 120: 72-8
|
|
|
|
|
|
10) Galie N, Beghetti M, Gatzoulis MA, et al. Bosentan therapy in patients with eisenmenger syndrome. A multicenter, double-blind, randomized, placebo-controlled study. Circulation. 2006; 114: 48-54
|
|
|
|
|
|
11) D'Alto M, Vizza CD, Romeo E, et al. Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical and haemodynamic effect. Heart. 2007; 93: 621-5
|
|
|
|
|
|
12) Singh TP, Rohit A, Grover A, et al. A randomized, Placebo-controlled, double blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. Am Heart J. 2006; 151: 851. e1-5
|
|
|
|
|
|
13) Chau EM, Fan KY, Chow WH. Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary artery hypertension. Int J Cardiol. 2007; 120: 301-5
|
|
|
|
|
|
14) Lim ZS, Salmon AP, Vettukattil JJ, et al. Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects. Int J Cardiol. 2007; 118: 178-82
|
|
|
|
|
|
15) Vida VL, Berggren H, Brawn WJ, et al. Risk of surgery for congenital heart disease in the Adult: a multicentered european study. Ann Thorac Surg. 2007; 83: 161-8
|
|
|
|
|
|
16) Sadiq A, Shyamkrishnan KG, TheodoreS, et al. Long-term functional assessment after correction of tetralogy of Fallot in adulthood. Ann Thorac Surg. 2007; 83: 1790-5
|
|
|
|
|
|
17) Horer J, Friebe J, Schreiber C, et al. Correction of tetralogy of Fallot and of pulmonary atresia with ventricular septal defect in adults. Ann Thorac Surg. 2005; 80: 2285-91
|
|
|
|
|
|
18) Chowdhury UK, Sathia S, Ruma R, et al. Histopathology of the right ventricular outflow tract and its relationship to clinical outcomes and arrhythmias in patients with tetralogy of Fallot. J Thorac Cardiovasc Surg. 2006; 132: 270-7
|
|
|
|
|
|
19) Marelli AJ, Perloff JK, Child JS. Pulmonary atresia with ventricular septal defect in adults. Circulation. 1994; 89: 243-51
|
|
|
|
|
|
20) d'Udekem Y, Alphonso N, Nergaad MA, et al. Pulmonary atresia with ventricular septal defects and major aortopulmonary collateral arteries: Uniforcalization brings no long-term benefits. J Thorac Cardiovasc Surg. 2005; 130: 1496-502
|
|
|
|
|
|
21) Belli E, Mace L, Ly M, et al. Surgical management of pulmonary atresia with ventricular septal defect in late adolescence and adulthood. Eur J Cardiothorac Surg. 2007; 31: 236-41
|
|
|
|
|
|
22) Khairy P, Poirier N, Mercier L. Univentricular Heart. Circulation. 2007; 115: 800-12
|
|
|
|
|
|
23) Warnes C, Somerville J. Tricuspid atresia in adolescents and adults: current state and late complications. Br Heart J. 1986; 56: 535-43
|
|
|
|
|
|
24) Ammash NM, Warnes CA, et al. Survival into adulthood of patients with unoperated single ventricle. Am J Cardiol. 1996; 77: 542-4
|
|
|
|
|
|
25) Hager A, Kaemmerer H, Eicken A, et al. Long-term survival of patients with univentricular heart not treated surgically. J Thorac Cardiovasc Surg. 2002; 123: 1214-7
|
|
|
|
|
|
26) Cheung YF, Cheng VYW, Chau AKT, et al. Outcome of infants with right atrial isomerism: is prognosis better with normal pulmonary venous drainage？ Heart. 2002; 87: 146-52
|
|
|
|
|
|
27) 神崎 歩, 里見元義, 安河内 聡, 他. 無脾症候群の長期予後の検討. 日小循誌. 2003; 19: 542-9
|
|
|
|
|
|
28) Moodie DS, Ritter DG, O'Fallon WM, et al. Long-term follow-up in the unoperated univentricular heart. Am J Cardiol. 1984; 53: 1124-8
|
|
|
|
|
|
29) Mott AR, Feltes TF, McKenzie ED, et al. Improved early results with the Fontan operation in adults with functional single ventricle. Ann Thorac Surg. 2004; 77: 1334-40
|
|
|
|
|
|
30) Gatzoulis MA, Munk MD, Williams WG, et al. Definitive palliation with cavopulmonary or aortopulmonary shunts for adults with single ventricle physiology. Heart. 2000; 83: 51-7
|
|
|
|
|
|
31) Day RW, Etheridge SP, Veasy LG, et al. Single ventricle palliation: Greater risk of complications with the Fontan procedure than with the bidirectional Glenn procedure alone. Int J Cardiol. 2006; 106: 201-10
|
|
|
|
|
|
32) Peries A, AI-Hay AA, Shinebourne EA. Outcome of the construction of a Blalock-Taussig shunt in adolescents and adults. Cardiol Young. 2005; 15: 368-72
|
|
|
|
|
|
33) McGuirk SP, Griselli M, Stumper OF, et al. Staged surgical management of hypoplastic left heart syndrome: a single institution 12 year experience. Heart. 2006; 92: 364-70
|
|
|
|
|
|
34) Wood P. Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. BMJ. 1958; 46: 755-62
|
|
|
|
|
|
35) Diller GP, Gatzoulis MA. Pulmonary Vascular Disease in Adults with Congenital heart disease. Circulation. 2007; 115: 1039-50
|
|
|
|
|
|
36) Saha A, Balakrishnan KG, Jaiswal PK, et al. Prognosis for patients with Eisenmenger syndrome of various aetiology. Int J Cardiol. 1994; 45: 199-207
|
|
|
|
|
|
37) Daliento L, Somerville J, Presbitero P, et al. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J. 1998; 19: 1845-55
|
|
|
|
|
|
38) Cantor WJ, Harrison DA, Moussadji JS, et al. Determinants of survival and length of survival in adults with Eisenmenger syndrome. Am J Cardiol. 1999; 84: 677-81
|
|
|
|
|
|
39) Niwa K, Perloff JK, Kaplan S, et al. Eisenmenger syndrome in adults: ventricular septal defect, truncus arteriosus, univentricular heart. J Am Coll Cardiol. 1999; 34: 223-32
|
|
|
|
|
|
40) Diller GP, Gatzoulis MA, et al. Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. Eur Heart J. 2006; 27: 1737-42
|
|
|
|
|
|
41) Takimoto E, Champion HC, Li M, et al. Chronic inhibition of cyclic GMP 5A prevents and reserves cardiac hypertrophy. Nat Med. 2005; 11: 214-22
|
|
|
|
|